Skip to main content

Advertisement

Table 1 Drug dosages per dose level

From: Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Dose level Ixazomib
orally on days 1, 8, 15
every 4 weeks
Carboplatin
i.v. on days 1,8 and 15
every 4 weeks
1 3 mg AUC 1.5
2 3 mg AUC 2
3 4 mg AUC 2
4 4 mg AUC 2.5
  1. AUC = area under the curve